Hyloris Pharmaceuticals SA reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 1.16 million compared to EUR 1.03 million a year ago. Net loss was EUR 6.63 million compared to EUR 4.94 million a year ago.
Hyloris Pharmaceuticals SA Reports Earnings Results for the Half Year Ended June 30, 2023
September 06, 2023 at 04:00 pm EDT
© S&P Capital IQ - 2023